Donald W. Degolyer
Director · Emergent BioSolutions Inc.
IndividualSelling only5 10b5-1 trades
- 2024
- Oct 7, 2026
- 5
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Donald W. Degolyer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sujata Tyagi Dayal - $201K in EBS purchases and sales in the last 12 months
- Kathryn C. Zoon - $144K in EBS purchases and sales in the last 12 months
- Keith Katkin - $128K in EBS purchases and sales in the last 12 months
- Paul Anthony Williams - $79K in EBS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Donald W. Degolyer?
Donald W. Degolyer is a corporate insider, tracked as Director of Emergent BioSolutions Inc. (EBS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Donald W. Degolyer submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Donald W. Degolyer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($784K) across all tracked filings.
